RVNC - Revance Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5477.91M
Enterprise Value 3251.65M
Trailing P/E N/A
Forward P/E 1-2.79
PEG Ratio (5 yr expected) 1-0.26
Price/Sales (ttm)125.30
Price/Book (mrq)2.16
Enterprise Value/Revenue 365.98
Enterprise Value/EBITDA 6-1.78

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-3,765.05%

Management Effectiveness

Return on Assets (ttm)-29.46%
Return on Equity (ttm)-62.41%

Income Statement

Revenue (ttm)3.81M
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)44.00%
Gross Profit (ttm)3.73M
EBITDA -141.64M
Net Income Avi to Common (ttm)-142.84M
Diluted EPS (ttm)-3.80
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)270.99M
Total Cash Per Share (mrq)6.16
Total Debt (mrq)31.53M
Total Debt/Equity (mrq)14.26
Current Ratio (mrq)8.13
Book Value Per Share (mrq)5.03

Cash Flow Statement

Operating Cash Flow (ttm)-104.52M
Levered Free Cash Flow (ttm)-71.09M

Trading Information

Stock Price History

Beta (3Y Monthly) 0.52
52-Week Change 3-64.21%
S&P500 52-Week Change 34.25%
52 Week High 331.65
52 Week Low 310.37
50-Day Moving Average 311.95
200-Day Moving Average 316.09

Share Statistics

Avg Vol (3 month) 3358.79k
Avg Vol (10 day) 3404.77k
Shares Outstanding 544.01M
Float 36.83M
% Held by Insiders 11.25%
% Held by Institutions 185.34%
Shares Short (May 15, 2019) 45.54M
Short Ratio (May 15, 2019) 416.42
Short % of Float (May 15, 2019) 419.46%
Short % of Shares Outstanding (May 15, 2019) 412.60%
Shares Short (prior month Apr 15, 2019) 45.21M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A